Mateon | HealthWire
Mateon Therapeutics - BIO Investor Forum | BIO
Windlas Biotech and Mateon Therapeutics to launch combined lung therapy, AI Telemedicine solution - Express Healthcare
Combined CA4P (Fosbretabulin) therapy in Cancer- Ashini R. Dias, Contributor | Cancer Biology
A Covid-19 treatment plan slowly emerges | Evaluate
Windlas Biotech and Mateon Therapeutics launch first-ever Drug-Device Lung Therapy Combined AI 360 platform for respiratory wellness - The Statesman
EX-4.1
Keeping an eye on Mateon Therapeutics (OTCQB: MATN) says GEN - Genetic Engineering & Biotechnology News - EmergingGrowth.com
Zacks Small-Cap Research
iBio Announces Collaboration with EdgePoint AI for Next Gen Biologics Manufacturing - DATAVERSITY
Mateon launches antiviral programme focussed on Covid-19
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
Consulting Agreement by and between the Company and Artius, | MATEON THERAPEUTICS INC | Business Contracts | Justia
MATEON'S C001- A GLOBAL PHASE 2 STUDY FOR OT-101 AGAINST
Mateon Halts Lead Candidate Development, Axes 60% of Workforce
Joint Venture Agreement relating to GMP Biotechnology Limited | MATEON THERAPEUTICS INC | Business Contracts | Justia
Windlas Biotech, Mateon Therapeutics launch integrated solution for respiratory wellness in India
Mateon Therapeutics
Mateon Completes Its Acquisition of PointR Data Inc. - DATAVERSITY
Mateon Therapeutics Archives - IndiaMedToday
Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - FFOODS Spectrum - Unleashing the Power of Food Science & Technology
